These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24529286)

  • 1. Pediatric drug development.
    Walson PD
    Clin Ther; 2014 Feb; 36(2):154-5. PubMed ID: 24529286
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. Can intellectual property save drug development?
    FitzGerald GA
    Science; 2012 Oct; 338(6106):483-4. PubMed ID: 23112323
    [No Abstract]   [Full Text] [Related]  

  • 3. Open innovation and intellectual property: time for a reboot?
    Judd DB
    Drug Discov Today; 2013 Oct; 18(19-20):907-9. PubMed ID: 23958455
    [No Abstract]   [Full Text] [Related]  

  • 4. Traditional drug-discovery model ripe for reform.
    Cressey D
    Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry and regulatory performance in 2012: a year in review.
    Dowden HM; Jahn R; Catka T; Jonsson A; Michael E; Miwa Y; Zinkand W
    Clin Pharmacol Ther; 2013 Sep; 94(3):359-66. PubMed ID: 23657160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges in pediatric drug development.
    Adamson PC
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):883-4. PubMed ID: 19209138
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
    [No Abstract]   [Full Text] [Related]  

  • 9. The Innovative Medicines Initiative: an engine for regulatory science.
    Goldman M; Seigneuret N; Eichler HG
    Nat Rev Drug Discov; 2015 Jan; 14(1):1-2. PubMed ID: 25503331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing drugs for pediatric malignancies.
    Adamson PC
    Clin Adv Hematol Oncol; 2013 Apr; 11(4):227-9. PubMed ID: 23604239
    [No Abstract]   [Full Text] [Related]  

  • 11. An industrial perspective on contemporary applications of PBPK models in drug discovery and development.
    Smith BJ
    Biopharm Drug Dispos; 2012 Mar; 33(2):53-4. PubMed ID: 22407480
    [No Abstract]   [Full Text] [Related]  

  • 12. The pediatric studies initiative: after 15 years have we reached the limits of the law?
    Milne CP; Davis J
    Clin Ther; 2014 Feb; 36(2):156-62. PubMed ID: 24529287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 14. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open innovation: share or die..
    Talaga P
    Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
    [No Abstract]   [Full Text] [Related]  

  • 17. Partnering for therapeutics discovery.
    Colvis CM; Devaney S; Brady LS; Hudson KL
    Clin Pharmacol Ther; 2013 Jan; 93(1):24-5. PubMed ID: 23187876
    [No Abstract]   [Full Text] [Related]  

  • 18. Virtual drug discovery with the rise of Chinese CROs.
    Zhang MQ
    Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343
    [No Abstract]   [Full Text] [Related]  

  • 19. The risky business of drug development in neurology.
    Craven R
    Lancet Neurol; 2011 Feb; 10(2):116-7. PubMed ID: 21256451
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinued drugs in 2010: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.